Please use this identifier to cite or link to this item:
Type: Artigo
Title: AMPK allostery : a therapeutic target for the management/treatment of diabetic nephropathy
Author: Ayinde, Kehinde Sulaimon
Olaoba, Olamide Tosin
Ibrahim, Boyenle
Lei, Du
Lu, Qian
Yin, Xiaoxing
Adelusi, Temitope Isaac
Abstract: Diabetic nephropathy (DN) is a chronic complication of diabetes mellitus (DM) with approximately 30–40% of patients with DM developing nephropathy, and it is the leading cause of end-stage renal diseases and diabetic morbidity. The pathogenesis of DN is primarily associated with irregularities in the metabolism of glucose and lipid leading to hyperglycemia-induced oxidative stress, which has been a major target together with blood pressure regulation in the control of DN progression. However, the regulation of 5′ adenosine monophosphate-activated protein kinase (AMPK), a highly conserved protein kinase for maintaining energy balance and cellular growth and repair has been implicated in the development of DM and its complications. Therefore, targeting AMPK pathway has been explored as a therapeutic strategy for the treatment of diabetes and its complication, although most of the mechanisms have not been fully elucidated. In this review, we discuss the structure of AMPK relevant to understanding its allosteric regulation and its role in the pathogenesis and progression of DN. We also identify therapeutic agents that modulate AMPK and its downstream targets with their specific mechanisms of action in the treatment of DN
Subject: Nefropatias diabéticas
Country: Estados Unidos
Editor: Elsevier
Rights: Fechado
Identifier DOI: 10.1016/j.lfs.2020.118455
Date Issue: 2020
Appears in Collections:IB - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.